Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing human C1 inhibitor

European Surgical Research

Volumn 36, Issue 3, 2004, Pages 142-147

  Inderbitzin, D ^a   Beldi, G ^a   Avital, I ^a   Vinci, G ^b   Candinas, D ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSTITUT PASTEUR   (France)

Author keywords

C1 inhibitor; Complement; Endothelial disruption; Ischemia reperfusion injury; Permeability index; Transgenic mouse

Indexed keywords

ALBUMIN; COMPLEMENT COMPONENT C1S INHIBITOR; IODINE 125;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRAVASATION; INTESTINE; LIVER ISCHEMIA; LUNG; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; REPERFUSION INJURY; TRANSGENIC MOUSE; TRUNK;

ALBUMINS; ANIMALS; CAPILLARY PERMEABILITY; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT PATHWAY, CLASSICAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; IODINE RADIOISOTOPES; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT PROTEINS; REPERFUSION INJURY;

EID: 2442596902     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077255     Document Type: Article

References (31)

1. Homer-Vanniasinkam S, Crinnion JN, Gough MJ: Post-ischaemic organ dysfunction: A review. Eur J Vasc Endovasc Surg 1997;14:195-203.
2. Seekamp A, Ward PA: Ischemia-reperfusion injury. Agents Actions Suppl 1993;41:137-152.
3. Kirschfink M: C1-inhibitor and transplantation. Immunobiology 2002;205:534-541.
4. Asghar SS, Pasch MC: Therapeutic inhibition of the complement system. Y2K update. Front Biosci 2000;5:E63-81.
5. Hill JH, Ward PA: The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 1971;133:885-900.
6. Riedemann NC, Ward PA: Complement in ischemia reperfusion injury. Am J Pathol 2003;162:363-367.
7. Hugli TE: Biochemistry and biology of anaphylatoxins. Complement 1986;3:111-127.
8. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE: C1-Esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2000;52:91-112.
9. Doekes G, van Es LA, Daha MR: C1-inactivator: Its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates. Immunology 1983;49:215-222.
10. Carter PE, Duponchel C, Tosi M, Fothergill JE: Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements. Eur J Biochem 1991;197:301-308.
11. Vinci G, Lynch NJ, Duponchel C, Lebastard TM, Milon G, Stover C, Schwaeble W, Tosi M: In vivo biosynthesis of endogenous and of human C1 inhibitor in transgenic mice: Tissue distribution and colocalization of their expression. J Immunol 2002;169:5948-5954.
12. Petersen SV, Thiel S, Jensen L, Vorup-Jensen T, Koch C, Jensenius JC: Control of the classical and the MBL pathway of complement activation. Mol Immunol 2000;37:803-811.
13. Chan RK, Ibrahim SI, Ding GY, Verna N, Hechtman HB, Moore FD: Complement deposition from reperfusion injury to skeletal muscle occurs primarily on type II muscle fibers. J Surg Res 2003;114:283.
14. Austen WG Jr, Kobzik L, Carroll MC, Hechtman HB, Moore FD Jr: The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int J Immunopathol Pharmacol 2003;16:1-8.
15. Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996;183:2343-2348.
16. de Smet BJ, de Boer JP, Agterberg J, Rigter G, Bleeker WK, Hack CE: Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. Blood 1993;81:56-61.
17. Bergamaschini L, Gobbo G, Gatti S, Caccamo L, Prato P, Maggioni M, Braidotti P, Di Stefano R, Fassati LR: Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver. Clin Exp Immunol 2001;126:412-420.
18. Horstick G, Berg O, Heimann A, Gotze O, Loos M, Hafner G, Bierbach B, Petersen S, Bhakdi S, Darius H, Horstick M, Meyer J, Kempski O: Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: Dose-related beneficial versus detrimental effects. Circulation 2001;104:3125-3131.
19. Salvatierra A, Velasco F, Rodriguez M, Alvarez A, Lopez-Pedrera R, Ramirez R, Carracedo J, Lopez-Rubio F, Lopez-Pujol A, Guerrero R: C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog. Am J Respir Crit Care Med 1997;155:1147-1154.
20. Lehmann TG, Heger M, Munch S, Kirschfink M, Klar E: In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia/reperfusion injury in the liver. Transplant Int 2000;13(suppl 1):S547-550.
21. Nielsen EW, Mollnes TE, Harlan JM, Winn RK: C1-inhibitor reduces the ischaemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping. Scand J Immunol 2002;56:588-592.
22. van den Berg CW, Aerts PC, van Dijk H: C1-inhibitor prevents PEG fractionation-induced, EDTA-resistant activation of mouse complement. Mol Immunol 1992;29:363-369.
23. Kyriakides C, Wang Y, Austen WG Jr, Favuzza J, Kobzik L, Moore FD Jr, Hechtman HB: Moderation of skeletal muscle reperfusion injury by a sLe(x)-glycosylated complement inhibitory protein. Am J Physiol 2001;281:C224-230.
24. Gibbs SA, Weiser MR, Kobzik L, Valeri CR, Shepro D, Hechtman HB: P-selectin mediates intestinal ischemic injury by enhancing complement deposition. Surgery 1996;119:652-656.
25. Carter WO, Bull C, Bortolon E, Yang L, Jesmok GJ, Gundel RH: A murine skeletal muscle ischemia-reperfusion injury model: Differential pathology in BALB/c and DBA/2N mice. J Appl Physiol 1998;85:1676-1683.
26. Lindsay TF, Hill J, Ortiz F, Rudolph A, Valeri CR, Hechtman HB, Moore FD Jr: Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann Surg 1992;216:677-683.
27. Kyriakides C, Austen WG Jr, Wang Y, Favuzza J, Moore FD Jr, Hechtman HB: Neutrophil mediated remote organ injury after lower torso ischemia and reperfusion is selectin and complement dependent. J Trauma 2000;48:32-38.
28. Seekamp A, Mulligan MS, Till GO, Ward PA: Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am J Pathol 1993;142:1217-1226.
29. Hancock WW, Koyamada N, Miyatake T, Candinas D, Meo T, Carroll M, Bach FH: Delayed xenograft rejection in sensitized mice with genetically induced interruptions of complement activation. 4th International Congress for Xenotransplantation, Nantes, 1997, p O65.
30. Cowan PJ, Aminian A, Barlow H, Brown AA, Chen CG, Fisicaro N, Francis DM, Goodman DJ, Han W, Kurek M, Nottle MB, Pearse MJ, Salvaris E, Shinkel TA, Stainsby GV, Stewart AB, d'Apice AJ: Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000;69:2504-2515.
31. Prather RS, Hawley RJ, Carter DB, Lai L, Greenstein JL: Transgenic swine for biomedicine and agriculture. Theriogenology 2003;59:115-123.